Predicting the Probability of Return To Work After Injury

March 24, 2022 updated by: Colin Graham, Chinese University of Hong Kong

Predicting the Probability of Return to Work After Injury in Hong Kong: Prospective Multicentre Cohort Study

To evaluate return to work (RTW) status after moderate and major trauma in Hong Kong at one year after injury. To derive reliable prediction models for return to work.

Study Overview

Status

Completed

Conditions

Detailed Description

Background:

Trauma is a leading cause not only of death worldwide but also of disability, and in Hong Kong it ranks sixth as a cause of death for all age groups. The implementation of trauma systems has improved the survival of injured patients in many settings including Hong Kong. However, the aim of trauma care for the injured person is not only to prolong life but also to restore patients to the best possible health status, and where applicable, to return to work. Survivors of trauma often experience late sequelae that have a major impact on almost all aspects of everyday life, and improvements in functional outcome and health status may continue for at least five years post-injury.

Objectives:

  1. to evaluate return to work (RTW) status after moderate and major trauma in Hong Kong at one year after injury;
  2. to derive reliable prediction models for RTW.

Study design:

This is a multi-centre, prospective long-term follow up cohort study of the 1163 trauma patients admitted to the Prince of Wales Hospital (PWH), Queen Elizabeth Hospital (QEH) and Tuen Mun Hospital (TMH) in Hong Kong in 2017-2018. Patients will be recruited within four weeks of ED attendance as soon as the patient is clinically stable and conscious. The follow-up period for return to work status of the 1163 trauma patients will extend from baseline to one year after trauma.

Study Type

Observational

Enrollment (Actual)

1115

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • NT
      • Sha Tin, NT, Hong Kong
        • Prince of Wales Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All adult patients aged 18 years or above who enter into the trauma registry of the hospitals involved in the study between 1 September 2017 and 31 August 2018 inclusive will be included.

Description

Inclusion Criteria:

  • Aged 18 years or above
  • Eligible for the trauma registry
  • Working or seeking employment before injury

Exclusion Criteria:

  • Isolated hip or pathological fractures
  • Injury severity score (ISS) of 1
  • Patients who are unwilling to enter the study
  • Patients who have left Hong Kong

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return to work status at 12 months after injury
Time Frame: 12 months after injury
The proportion of trauma patients who return to work at 12 months after injury
12 months after injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Glasgow Outcome Scale-Extended (GOSE) over time
Time Frame: On admission, 30 days after injury, 3 months after injury, 6 months after injury, 9 month after injury and 12 months after injury
Change of GOSE over time
On admission, 30 days after injury, 3 months after injury, 6 months after injury, 9 month after injury and 12 months after injury

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2017

Primary Completion (ACTUAL)

December 31, 2019

Study Completion (ACTUAL)

February 28, 2022

Study Registration Dates

First Submitted

July 7, 2017

First Submitted That Met QC Criteria

July 13, 2017

First Posted (ACTUAL)

July 17, 2017

Study Record Updates

Last Update Posted (ACTUAL)

April 5, 2022

Last Update Submitted That Met QC Criteria

March 24, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • CREC2016.667-T

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trauma

3
Subscribe